The future is now for the treatment of chronic myelogenous leukemia.
Becze
Elisa
E
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D002986:Clinical Trials as Topic; D018450:Disease Progression; D016903:Drug Monitoring; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D024802:Nurse's Role; D009859:Oncology Nursing / Q000458:organization & administration*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*